Effectiveness of eslicarbazepine acetate in dependency of baseline anticonvulsant therapy: Results from a German prospective multicenter clinical practice study
Eslicarbazepine acetate (ESL) is a third-generation antiepileptic drug (AED) approved as monotherapy for partial-onset seizures in adults and as adjunctive therapy in patients aged above 6 years in the European Union (EU). The prospective observational Zebinix Effects in DEpendency of B...read more
Mentioned in this Paper
Aed a 1 allergen
References currently unavailable
We're still populating references for this paper, please check back later.
No citations available
This paper may not have been cited yet.